• Parkin-Mediated Ku70 Ubiquitination Drives Lens Cell Apoptos

  2026-05-20

  This study reveals that Parkin, an E3 ubiquitin ligase, targets the DNA repair protein Ku70 for ubiquitination and degradation, promoting apoptosis in lens epithelial cells under oxidative stress. These findings elucidate a mechanistic link between protein turnover, mitochondrial dynamics, and age-related cataract formation, suggesting new directions for therapeutic intervention.

• Ibrexafungerp Efficacy Against Fluconazole-Resistant Candida

  2026-05-19

  This study demonstrates that ibrexafungerp retains potent in vitro and in vivo activity against Candida auris strains resistant to fluconazole, even when treatment initiation is delayed. These findings highlight the urgent need for new antifungal options and inform the design of future drug resistance and susceptibility studies.

• Clathrin-Mediated Entry of Grass Carp Reovirus: PKC Inhibito

  2026-05-19

  Wang et al. (2018) elucidate that type III grass carp reovirus (GCRV104) invades host cells via clathrin-mediated, pH-dependent endocytosis, with entry critically reliant on dynamin activity. Their pharmacological analysis identifies selective protein kinase C (PKC) inhibition, including the use of Rottlerin, as an effective strategy to block viral entry and replication, providing a foundation for targeted antiviral research in aquaculture virology.

• Penicillin G Sodium: Applied Protocols and Troubleshooting I

  2026-05-18

  Leverage Penicillin G Sodium’s robust inhibition of bacterial cell wall biosynthesis for reliable Gram-positive control in research and clinical workflows. This guide details step-by-step experimental enhancements, cross-study troubleshooting strategies, and actionable insights from recent transporter inhibition research to elevate your microbiological assays.

• (-)-Blebbistatin (SKU B1387): Data-Driven Solutions for Cell

  2026-05-18

  This article provides biomedical researchers and laboratory technicians with a scenario-driven, evidence-based guide to overcoming common assay challenges using (-)-Blebbistatin (SKU B1387). Through practical Q&A blocks, it demonstrates how this non-muscle myosin II inhibitor enhances reproducibility and selectivity in cell viability, migration, and cytoskeletal dynamics assays. All recommendations are grounded in validated protocols, literature, and robust supplier data.

• Biotin-tyramide Signal Amplification: Applied Workflows & Tr

  2026-05-17

  Biotin-tyramide enables ultra-sensitive, high-resolution detection in immunohistochemistry and in situ hybridization through enzyme-mediated signal amplification. This guide translates recent neurodevelopmental research into actionable protocols, advanced applications, and troubleshooting strategies for robust biotin phenol-based assays.

• L-NMMA Acetate: NOS Pathway Inhibition for Research Precisio

  2026-05-16

  L-NMMA acetate, also known as N(G)-monomethyl-L-arginine acetate, is a high-purity, water-soluble inhibitor of all nitric oxide synthase isoforms. This compound enables controlled modulation of nitric oxide signaling in diverse research models. Its verified use extends from inflammation and cardiovascular studies to stem cell and regenerative medicine experiments, supporting reproducible, quantitative pathway interrogation.

• D-Luciferin: Optimizing Firefly Luciferase Substrate Workflo

  2026-05-15

  D-Luciferin stands as the gold-standard substrate for firefly luciferase, enabling ultrasensitive bioluminescence imaging across a wide range of cellular and animal models. Discover how APExBIO’s high-purity D-Luciferin streamlines promoter activity monitoring, ATP quantification, and non-invasive tumor assessment, with actionable protocols and troubleshooting insights for reproducible, high-impact data.

• CPI-613: Redefining Tumor Cell Metabolism via Mitochondrial

  2026-05-15

  Explore how CPI-613 (6,8-bis(benzylsulfanyl)octanoic acid) pioneers cancer research by targeting mitochondrial metabolism with unique mechanisms and practical assay insights. This article uncovers new strategies for apoptosis and tumor cell metabolism studies, distinct from existing guides.

• Asunaprevir (BMS-650032): Precision HCV RNA Replication Inhi

  2026-05-14

  Asunaprevir (BMS-650032) redefines hepatitis C virus research with its nanomolar potency, pan-genotypic activity, and robust hepatotropic profile. This article delivers actionable workflows and troubleshooting strategies, contextualized by cutting-edge reference findings, to help researchers maximize the impact of their HCV NS3 protease inhibitor studies.

• Poly (I:C): Unleashing Innate Immunity for Translational Imp

  2026-05-14

  This thought-leadership article unpacks how Poly (I:C), a synthetic double-stranded RNA analog and TLR3 agonist from APExBIO, catalyzes robust innate immune responses and drives next-gen translational strategies. We blend mechanistic insights—such as dendritic cell maturation and interferon induction—with strategic guidance for overcoming experimental and clinical barriers. By integrating recent neuroimmune findings and referencing the latest competitive literature, we offer a credible, actionable roadmap for translational researchers seeking to leverage Poly (I:C) in disease modeling, immunotherapy, and regenerative workflows.

• CLK2 Inhibition Overcomes Platinum Resistance in Ovarian Can

  2026-05-13

  This study identifies Cdc2-like kinase 2 (CLK2) as a critical mediator of platinum resistance in ovarian cancer by promoting DNA repair through BRCA1 phosphorylation. Targeting CLK2 provides a mechanistic rationale for overcoming chemoresistance, with implications for alternative splicing modulation and therapy development.

• IWR-1-endo: Wnt Signaling Inhibitor Workflows & Pitfalls

  2026-05-13

  IWR-1-endo delivers nanomolar potency and mechanistic specificity for Wnt/β-catenin pathway inhibition, enabling robust colorectal cancer research and regenerative biology studies. This guide distills experimental strategies, troubleshooting, and protocol optimizations for maximizing the utility of IWR-1-endo in advanced cell and animal models.

• Honokiol: Applied Workflows for NF-κB Inhibition in Cancer R

  2026-05-12

  Honokiol, a bioactive small molecule, is redefining cancer and inflammation assay design through potent NF-κB pathway inhibition and robust antioxidant activity. This article translates recent in vitro methodology advances into actionable, troubleshooting-rich workflows, empowering researchers to optimize Honokiol’s use across viability, angiogenesis, and immunometabolic studies. Discover protocol enhancements, evidence-backed troubleshooting, and perspective on Honokiol’s evolving research impact.

• Low-Cost OP-DLP Platform Enables High-Throughput Hydrogel Pr

  2026-05-12

  This study introduces an open-platform digital light printer (OP-DLP) for precise, high-throughput hydrogel synthesis and spatially controlled light activation in standard 96-well plates. The innovation streamlines the fabrication of thin, uniformly patterned hydrogels, addressing bottlenecks in cell-based assay reproducibility and scalability.

16389 records 3/1093 page Previous Next 12345 下5页 Last page